← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2021Last known activity
Sep 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (21 distinct, 17 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Recent trials (36)
- NCT07182526Lead sponsorPhase 2Sep 20, 2025
- NCT07182526Sponsor investigatorPhase 2Sep 20, 2025
- NCT07133659Sponsor investigatorPhase 4Jun 8, 2025
- NCT07133659Lead sponsorPhase 4Jun 8, 2025
- NCT06900881Lead sponsorPhase 2/Phase 3Apr 6, 2025
- NCT06900881Sponsor investigatorPhase 2/Phase 3Apr 6, 2025
- NCT06888453OfficialPhase 1Mar 23, 2025
- NCT06888453Sponsor investigatorPhase 1Mar 23, 2025
- NCT06888453Lead sponsorPhase 1Mar 23, 2025
- NCT06850571Lead sponsorPhase 4Feb 20, 2025
- NCT06850571Sponsor investigatorPhase 4Feb 20, 2025
- NCT06798402CollaboratorPhase 2Feb 7, 2025
- NCT07033351Sponsor investigatorN/AFeb 1, 2025
- NCT07033351Lead sponsorN/AFeb 1, 2025
- NCT06792812Sponsor investigatorPhase 2Jan 25, 2025
Details
- Last known activity
- Sep 20, 2025